Brands: Vyvanse · Lisdexamfetamine Dimesylate
Average across 42 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novadoz Pharmaceuticals LLC | generic | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 6 | SUPPLYING |
| SpecGx LLC | unknown | 6 | SUPPLYING |
| Takeda Pharmaceuticals America, Inc. | unknown | 6 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 6 | SUPPLYING |
| Granules Pharmaceuticals Inc. | unknown | 6 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 6 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lisdexamfetamine Dimesylate Tablet, Chewable — reported in shortage by Novadoz Pharmaceuticals LLC. Therapeutic category: Psychiatry.
